1
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
Condition(s):Low Grade B Cell LymphomaLast Updated:September 25, 2019Terminated
Low Grade B-cell Lymphoma: 99 Clinical Trials, Page 1 of 10
Hide Studies Not Open or Pending
2
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
Condition(s):B-cell LymphomaLast Updated:September 4, 2020Terminated
3
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
Condition(s):Lymphoma, B-CellLast Updated:September 22, 2016Completed
4
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma
Condition(s):MALT LymphomaLast Updated:March 28, 2016Completed
5
A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma; Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell; Lymphomas: Non-HodgkinLast Updated:March 14, 2017Completed
6
In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Condition(s):Low-Grade B-cell LymphomaLast Updated:September 22, 2022Completed
7
Yttrium-90 Ibritumomab Tiuxetan (Zevalin) With BEAM in Relapsed Low Grade B-Cell Lymphoma
Condition(s):B-Cell LymphomaLast Updated:September 8, 2006Completed
8
Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies
Condition(s):Lymphoma, Non-HodgkinLast Updated:December 12, 2016Completed
9
A Phase I/II Study of Intratumoral Injection of SD-101
Condition(s):Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Splenic Marginal Zone LymphomaLast Updated:November 27, 2019Completed
10
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin’s Lymphoma
Condition(s):Lymphoma, Non-HodgkinLast Updated:December 13, 2016Completed